Loading...
Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris(®)) in Pituitary-Suppressed Healthy Women
This was a Phase I, open-label, randomized, two-period, two-sequence crossover study [ClinicalTrials.gov NCT02317809 (https://www.clinicaltrials.gov/ct2/show/NCT02317809); EudraCT 2014-003506-32] assessing the bioequivalence of the liquid and freeze-dried formulations of fixed-dose, fixed-ratio (2:1...
Na minha lista:
| Udgivet i: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768635/ https://ncbi.nlm.nih.gov/pubmed/29375477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00371 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|